Abstract
Autologous blood salvage or cell salvage gained popularity during the HIV era. As HIV is not a threat to the blood supply any more, and as surgical technology has become more non-invasive, it raises the question as to whether there is still a role for autologous blood salvage. This author would argue that there are continuing threats to the blood supply, including an inadequate supply and the economic burden of allogeneic blood that it may be too soon to retire autologous blood salvage. In addition, there are growth opportunities that have been untapped such as trauma, cancer surgery and obstetrical care. If clinicians would get over their theoretical fears of salvage use in these environments, it would further extend the available blood supply.
Downloads
- Abstract viewed - 23 times
- pdf downloaded - 7 times